Journal of Oral Pathology & Medicine最新文献

筛选
英文 中文
Differential Expression of Selected miRNAs in CD44-Enriched Cell Populations of Oral Squamous Cell Carcinoma. cd44富集的口腔鳞状细胞癌细胞群中选定miRNAs的差异表达
IF 2.3 3区 医学
Journal of Oral Pathology & Medicine Pub Date : 2026-11-09 DOI: 10.1111/jop.70196
Milica Jaksic Karisik, Katarina Zeljic, Vitomir Konstantinovic, Branko Dozic, Nadja Nikolic, Dijana Mitic, Jelena Milasin
{"title":"Differential Expression of Selected miRNAs in CD44-Enriched Cell Populations of Oral Squamous Cell Carcinoma.","authors":"Milica Jaksic Karisik, Katarina Zeljic, Vitomir Konstantinovic, Branko Dozic, Nadja Nikolic, Dijana Mitic, Jelena Milasin","doi":"10.1111/jop.70196","DOIUrl":"https://doi.org/10.1111/jop.70196","url":null,"abstract":"<p><strong>Background: </strong>Oral squamous cell carcinoma (OSCC) remains a clinically challenging malignancy characterized by marked biological heterogeneity, high recurrence rates, and limited progress in survival outcomes. MicroRNAs (miRNAs) have emerged as key post-transcriptional regulators involved in carcinogenesis and cancer progression, yet their expression patterns within phenotypically distinct tumor cell subpopulations, particularly CD44<sup>+</sup> cancer stem cells-like (CSC-like), remain insufficiently characterized.</p><p><strong>Objective: </strong>This study investigated the expression of five candidate miRNAs (hsa-miR-26a-5p, hsa-miR-31-5p, hsa-miR-133a-5p, hsa-miR-491-3p, and hsa-miR-532-3p) in OSCC on multiple levels: public dataset analysis, whole-tissue expression profiling, and evaluation within sorted CD44<sup>+</sup> and CD44<sup>-</sup> primary cell populations.</p><p><strong>Results: </strong>TCGA-HNSC dataset analysis revealed upregulation of hsa-miR-31-5p and hsa-miR-532-3p (p < 0.0001), alongside downregulation of hsa-miR-26a-5p and hsa-miR-133a-5p in tumor tissue (p < 0.0001, p = 0.0015, respectively), whereas hsa-miR-491-3p showed no significant difference (p = 0.925). In our OSCC cohort (n = 20 OSCC, n = 10 controls), hsa-miR-31-5p was significantly upregulated (p = 0.0086), while hsa-miR-26a-5p, hsa-miR-133a-5p, and hsa-miR-491-3p were markedly downregulated in tumor samples compared with normal mucosa (p = 0.0363, p = 0.0029, p < 0.0001, respectively). Although hsa-miR-532-3p exhibited an upward trend, this change did not reach statistical significance. CD44 expression was significantly higher in OSCC tissues, particularly in advanced TNM stages (p = 0.0319), confirming its association with tumor aggressiveness. To explore miRNA dysregulation within CD44-defined subpopulations, CD44<sup>+</sup> and CD44<sup>-</sup> cells were isolated from primary OSCC cultures (n = 5 primary cultures). hsa-miR-133a-5p, hsa-miR-491-3p, and hsa-miR-532-3p were significantly less expressed in CD44<sup>+</sup>cells than in CD44<sup>-</sup>cells (p = 0.0142, p = 0.0015 and p = 0.0002), indicating that their downregulation characterizes the CD44<sup>+</sup>-enriched fraction. These findings suggest that the tumor-suppressive miRNAs hsa-miR-133a-5p, hsa-miR-491-3p, and hsa-miR-532-3p are selectively dysregulated within CSC-like cells, potentially contributing to stemness-associated signaling and therapy resistance.</p><p><strong>Conclusion: </strong>Overall, this study integrates bioinformatic, tissue-level, and cell-specific analyses to identify miRNAs implicated in CSC-like biology in OSCC, highlighting their potential as biomarkers and targets for therapeutic strategies aimed at eradicating chemotherapy-resistant CSC-like populations.</p>","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sample-Efficient Transfer Learning for Histopathological Detection of HNSCC 样本高效迁移学习在HNSCC组织病理学检测中的应用。
IF 2.3 3区 医学
Journal of Oral Pathology & Medicine Pub Date : 2026-11-02 Epub Date: 2026-08-31 DOI: 10.1111/jop.70181
Till Nicke, Fleming Wolf-Eli Michelsen, Jan-Raphael Schäfer, Jonas Wuester, Marc Christian Metzger, Rainer Schmelzeisen, Gian Kayser, Andreas Weber-Steinhilber, Joachim Georgii, Johannes Lotz, Leonard Simon Brandenburg
{"title":"Sample-Efficient Transfer Learning for Histopathological Detection of HNSCC","authors":"Till Nicke,&nbsp;Fleming Wolf-Eli Michelsen,&nbsp;Jan-Raphael Schäfer,&nbsp;Jonas Wuester,&nbsp;Marc Christian Metzger,&nbsp;Rainer Schmelzeisen,&nbsp;Gian Kayser,&nbsp;Andreas Weber-Steinhilber,&nbsp;Joachim Georgii,&nbsp;Johannes Lotz,&nbsp;Leonard Simon Brandenburg","doi":"10.1111/jop.70181","DOIUrl":"10.1111/jop.70181","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Head and neck squamous cell carcinoma (HNSCC) is a common malignancy with increasing incidence. Histopathological assessment remains the diagnostic gold standard, but is labor-intensive and affected by a growing shortage of specialized pathologists. Limited availability of annotated data poses a major challenge for AI-based support tools in digital pathology.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We evaluated the transfer performance of a domain-specific foundation model, Tissue Concepts, compared to standard ImageNet pretraining for HNSCC detection in histopathological whole slide images. A multicentric, retrospective dataset comprising digitized H&amp;E-stained slides from The Cancer Imaging Archive was used (390 slides, 268 HNSCC cases, 112 patients). Tumor regions were annotated by expert pathologists. Model representations were assessed without task-specific fine-tuning using a standardized classifier probe. Sample efficiency was investigated on patch-based and patient-based levels to estimate the number of annotated cases required for robust performance.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The foundation model consistently outperformed ImageNet pretraining across all experiments. On a patch-based level, Tissue Concepts achieved substantially higher discrimination performance with minimal training data (AUROC = 0.70 vs. = 0.50 using only 1 patch). On a patient-based level, the foundation model reached robust performance with a limited number of annotated cases (AUROC = 0.90 with 10 cases), whereas ImageNet-based representations showed slightly inferior performance despite substantially larger training sets (AUROC = 0.87 with 50 cases). Performance improvements plateaued beyond 10 cases, indicating diminishing returns with additional annotations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Domain-specific foundation models enable competitive HNSCC detection under annotation-scarce conditions. However, performance depends on the representativeness of annotated cases and tumor heterogeneity across anatomical sites and institutions. Further multicenter and prospective studies are required to assess generalizability and integration into routine histopathological workflows.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":"55 10","pages":"1113-1120"},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jop.70181","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148864922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of Aurora Kinase A Prevents Malignant Transformation in Oral Leukoplakia 抑制极光激酶A可预防口腔白斑的恶性转化。
IF 2.3 3区 医学
Journal of Oral Pathology & Medicine Pub Date : 2026-11-02 Epub Date: 2026-09-01 DOI: 10.1111/jop.70177
Fengying Yin, Mengjun Li, Yi Xu, Chuan Xin, Yining Li, Qianming Chen
{"title":"Inhibition of Aurora Kinase A Prevents Malignant Transformation in Oral Leukoplakia","authors":"Fengying Yin,&nbsp;Mengjun Li,&nbsp;Yi Xu,&nbsp;Chuan Xin,&nbsp;Yining Li,&nbsp;Qianming Chen","doi":"10.1111/jop.70177","DOIUrl":"10.1111/jop.70177","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Aurora Kinase A (AURKA), a highly conserved and potent kinase, is frequently overexpressed in diverse cancers. However, its role in the malignant transformation (MT) of oral mucosa remains poorly understood. This study investigated the expression pattern of AURKA and evaluated the therapeutic potential of its inhibitor in oral leukoplakia (OLK), the most representative oral potentially malignant disorder.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Immunohistochemistry was performed on clinical samples (21 normal controls, 27 OLK, 23 MT of OLK) to examine AURKA expression and its correlation with clinicopathological characteristics. The inhibitory effect of targeting AURKA on tumor proliferation <i>was</i> verified in vitro using two oral squamous cell carcinoma (OSCC) cell lines. Additionally, the chemopreventive effect of the AURKA inhibitor Alisertib on MT was assessed using a 4-nitroquinoline oxide (4NQO)–induced mouse OLK model.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>AURKA expression levels positively correlated with the malignant progression of OLK. Significantly higher AURKA expression percentages were observed in non-homogeneous lesions (10.39% ± 4.28% vs. 3.53% ± 4.22% homogeneous, <i>p</i> &lt; 0.001), lesions ≥ 2 cm<sup>2</sup> (11.19% ± 4.55% vs. 4.69% ± 4.36% &lt; 2 cm<sup>2</sup>, <i>p</i> &lt; 0.01), and lesions with high-risk dysplasia (12.10% ± 4.04% vs. 4.59% ± 4.12% low-risk dysplasia, <i>p</i> &lt; 0.001). Targeting AURKA significantly inhibited the proliferation of OSCC cells in vitro. Furthermore, Alisertib treatment effectively suppressed oral mucosa carcinogenesis in the 4NQO model.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Increased AURKA expression may represent an early molecular event in OLK carcinogenesis, and targeting AURKA with alisertib is a candidate for potential applications in the management of OLK.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":"55 10","pages":"1089-1098"},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148864733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of Selected Epithelial-Mesenchymal Transition and Immune Checkpoint Markers in Predicting Malignant Transformation of Oral Leukoplakia 选择性上皮-间质转化和免疫检查点标记在预测口腔白斑恶性转化中的预后价值。
IF 2.3 3区 医学
Journal of Oral Pathology & Medicine Pub Date : 2026-11-02 Epub Date: 2026-09-27 DOI: 10.1111/jop.70187
Jiveswara Vijiakumar, Thomas George Kallarakkal, Lee Peng Karen-Ng, Samadara Siriwardena, Wanninayake Mudiyanselage Tilakaratne
{"title":"Prognostic Value of Selected Epithelial-Mesenchymal Transition and Immune Checkpoint Markers in Predicting Malignant Transformation of Oral Leukoplakia","authors":"Jiveswara Vijiakumar,&nbsp;Thomas George Kallarakkal,&nbsp;Lee Peng Karen-Ng,&nbsp;Samadara Siriwardena,&nbsp;Wanninayake Mudiyanselage Tilakaratne","doi":"10.1111/jop.70187","DOIUrl":"10.1111/jop.70187","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This study investigates the prognostic potential of epithelial-mesenchymal transition (EMT) markers (E-cadherin, N-cadherin, Twist) and immune checkpoint markers (PD-1, PD-L1) in predicting malignant transformation (MT) of oral leukoplakia (OL).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methodology</h3>\u0000 \u0000 <p>Immunohistochemistry (IHC) was performed on 56 OL tissue samples, categorized equally into progressive (transformed to higher-grade dysplasia or OSCC within 3 years) and non-progressive groups. Expression levels of E-cadherin, N-cadherin, Twist, PD-1, and PD-L1 were systematically assessed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Progressive OL cases showed descriptive trends of lower E-cadherin expression, higher N-cadherin and Twist expression compared with non-progressive cases; however, these EMT-marker differences were not statistically significant. PD-1 expression was significantly higher in progressive OL (<i>p</i> = 0.038) compared with non-progressive OL. When stratified into non-progressive, dysplasia-progressive, and OSCC-progressive subsets, PD-L1 expression demonstrated significant variation (<i>p</i> = 0.018). Higher PD-1 expression was significantly associated with progressive OL in males (<i>p</i> = 0.02) and correlated with a shorter time to progression (τb = 0.456, <i>p</i> = 0.004).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The findings suggest that immune checkpoint markers, particularly PD-1 and PD-L1, may be associated with progression in OL and may warrant further validation as adjunctive prognostic markers.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":"55 10","pages":"1162-1172"},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Care of OLP Patients: A Retrospective Study From a Single Hospital Outpatient Clinic OLP患者的长期护理:来自一家医院门诊的回顾性研究。
IF 2.3 3区 医学
Journal of Oral Pathology & Medicine Pub Date : 2026-11-02 Epub Date: 2026-09-04 DOI: 10.1111/jop.70179
F. Scilla, G. Gioco, L. Ferrero, R. Castagnola, A. Zafarone, L. Cimino, M. Tranfa, C. Rupe, C. Lajolo
{"title":"Long-Term Care of OLP Patients: A Retrospective Study From a Single Hospital Outpatient Clinic","authors":"F. Scilla,&nbsp;G. Gioco,&nbsp;L. Ferrero,&nbsp;R. Castagnola,&nbsp;A. Zafarone,&nbsp;L. Cimino,&nbsp;M. Tranfa,&nbsp;C. Rupe,&nbsp;C. Lajolo","doi":"10.1111/jop.70179","DOIUrl":"10.1111/jop.70179","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Oral lichen planus (OLP) is a chronic immune-mediated disorder with malignant potential. However, its real-world clinical course remains incompletely characterized. This study aimed to describe the natural clinical–histopathological trajectory of OLP in a single tertiary centre and to identify factors associated with dysplasia and malignant transformation over time.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a single-centre retrospective cohort study including patients diagnosed with OLP and followed between 2007 and 2024 at the Oral Medicine Unit of Fondazione Policlinico Universitario A. Gemelli IRCCS. Demographic, clinical (red vs. white phenotype and lesion distribution), microbiological (Candida spp.), therapeutic, and histopathological variables were collected across follow-up. Univariate and multivariable logistic regression models were used to evaluate factors associated with dysplasia and malignant transformation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 308 screened patients, 246 met inclusion criteria (173 women, 70.3%; mean age 63.2 ± 15.0 years) with a mean follow-up of 55.5 ± 37.0 months. At baseline, Candida spp. colonization was detected in 55 patients (22.4%) and was more frequent in red-type OLP than white-type lesions (33.3% vs. 17.0%; OR 2.44, 95% CI 1.32–4.53; <i>p</i> = 0.005). During follow-up, 33 patients (13.4%) developed fungal infection despite an initially negative swab. Epithelial dysplasia emerged in 42 patients (17.1%). In multivariable analysis, dysplasia was independently associated with increasing age (OR 1.06, 95% CI 1.03–1.10; <i>p</i> = 0.0001) and red-type OLP(OR 2.24, 95% CI 1.10–4.55; <i>p</i> = 0.026). Eight patients (3.25%) developed infiltrative OSCC after a mean interval of 28.3 months from OLP diagnosis (range 4–55).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>In this long-term single-centre cohort, OLP frequently evolved through dysplasia during follow-up, and malignant transformation occurred in a minority of patients. Older age and red-type phenotype characterized patients more likely to develop dysplasia, while malignant transformation was more frequent in the case of previously documented dysplastic lesions, in keeping with the notion of dysplasia as a step along the carcinogenic pathway, older age, and diffuse lesions.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":"55 10","pages":"1121-1136"},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jop.70179","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148890973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Papilliferous Keratoameloblastoma: What Is It, and Who Coined the Eponym? 乳头状角膜成釉细胞瘤:什么是乳头状角膜成釉细胞瘤,谁创造了这个名字?
IF 2.3 3区 医学
Journal of Oral Pathology & Medicine Pub Date : 2026-11-02 Epub Date: 2026-09-24 DOI: 10.1111/jop.70183
Fumio Ide, Shinnichi Sakamoto, Michiko Nishimura, Yuji Miyazaki, Kentaro Kikuchi
{"title":"Papilliferous Keratoameloblastoma: What Is It, and Who Coined the Eponym?","authors":"Fumio Ide,&nbsp;Shinnichi Sakamoto,&nbsp;Michiko Nishimura,&nbsp;Yuji Miyazaki,&nbsp;Kentaro Kikuchi","doi":"10.1111/jop.70183","DOIUrl":"10.1111/jop.70183","url":null,"abstract":"","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":"55 10","pages":"1081-1083"},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149039426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Infrared and Dual-Wavelength Photobiomodulation Therapy on Mandibular Bone Healing Following Radiotherapy and Tooth Extraction: An Experimental Study 红外和双波长光生物调节治疗对放疗拔牙后下颌骨愈合影响的实验研究。
IF 2.3 3区 医学
Journal of Oral Pathology & Medicine Pub Date : 2026-11-02 Epub Date: 2026-09-21 DOI: 10.1111/jop.70186
Göksal Keldal, Sefa Çolak, Asiye Yancı, Gülhan Güler Avcı, Rutkay Fırat Bulut, Bilal Bahar, Yunus Balel, Fikret Gevrek
{"title":"Effects of Infrared and Dual-Wavelength Photobiomodulation Therapy on Mandibular Bone Healing Following Radiotherapy and Tooth Extraction: An Experimental Study","authors":"Göksal Keldal,&nbsp;Sefa Çolak,&nbsp;Asiye Yancı,&nbsp;Gülhan Güler Avcı,&nbsp;Rutkay Fırat Bulut,&nbsp;Bilal Bahar,&nbsp;Yunus Balel,&nbsp;Fikret Gevrek","doi":"10.1111/jop.70186","DOIUrl":"10.1111/jop.70186","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Osteoradionecrosis (ORN) is a serious complication of head and neck radiotherapy characterized by impaired bone healing. Infrared photobiomodulation therapy (IR-PBMT) and dual-wavelength photobiomodulation therapy (Dual-PBMT) have been proposed as non-invasive approaches to enhance bone regeneration.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Twenty-nine male Wistar–Albino rats were included. An experimental protocol designed to induce mandibular ORN was performed using a single 35 Gy radiation dose followed by mandibular molar extraction. Animals were allocated to four groups: control, radiotherapy plus extraction (RT + EX), RT + EX + IR-PBMT, and RT + EX + Dual-PBMT. IR-PBMT was performed using a 940 nm diode laser, whereas Dual-PBMT combined 632–650 nm red and 904–940 nm infrared wavelengths. Both PBMT protocols were applied extraorally for 14 consecutive days. Bone samples were evaluated histopathologically and immunohistochemically for alkaline phosphatase (ALP), bone morphogenetic protein-2 (BMP-2), osteonectin (ONC), and tartrate-resistant acid phosphatase (TRAP).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The RT + EX group exhibited severe inflammation and tissue destruction, whereas both PBMT-treated groups showed reduced inflammation and partial epithelialization. Osteogenic marker expression was significantly lower and TRAP expression was significantly higher in the RT + EX group than in the control group (<i>p</i> &lt; 0.05). Compared with the RT + EX group, both IR-PBMT and Dual-PBMT significantly increased ALP, BMP-2, and ONC expression and reduced TRAP expression (<i>p</i> &lt; 0.05). ALP expression was significantly higher in the Dual-PBMT group than in the IR-PBMT group, whereas no significant differences between the two protocols were observed for BMP-2, ONC, or TRAP.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Both IR-PBMT and Dual-PBMT improved the evaluated histological and bone-remodeling parameters following radiotherapy and tooth extraction. Because the control animals did not undergo tooth extraction, comparisons with the control group should be interpreted cautiously. Although Dual-PBMT produced a greater increase in ALP expression, the findings do not demonstrate the overall superiority of one PBMT protocol over the other. Both approaches may represent promising adjunctive strategies for mitigating radiation-associated impairment of mandibular bone healing.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":"55 10","pages":"1152-1161"},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149012041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clarifications Regarding Methodological Aspects of Micronucleus Assessment in Oral Epithelial Cells in Fanconi Anemia 关于范可尼贫血患者口腔上皮细胞微核评估方法学方面的澄清。
IF 2.3 3区 医学
Journal of Oral Pathology & Medicine Pub Date : 2026-11-02 Epub Date: 2026-09-27 DOI: 10.1111/jop.70185
Bárbara Soldatelli Ballardin, Pâmela Olivia de Moura, Pedro Leonardo Czmola de Lima, Juliana Lucena Schussel, Cassius Carvalho Torres-Pereira
{"title":"Clarifications Regarding Methodological Aspects of Micronucleus Assessment in Oral Epithelial Cells in Fanconi Anemia","authors":"Bárbara Soldatelli Ballardin,&nbsp;Pâmela Olivia de Moura,&nbsp;Pedro Leonardo Czmola de Lima,&nbsp;Juliana Lucena Schussel,&nbsp;Cassius Carvalho Torres-Pereira","doi":"10.1111/jop.70185","DOIUrl":"10.1111/jop.70185","url":null,"abstract":"","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":"55 10","pages":"1086-1088"},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral Cell Cytogenetic Biomarkers for Monitoring Genomic Instability in Fanconi Anemia 监测范可尼贫血基因组不稳定性的口腔细胞遗传学生物标志物。
IF 2.3 3区 医学
Journal of Oral Pathology & Medicine Pub Date : 2026-11-02 Epub Date: 2026-09-27 DOI: 10.1111/jop.70184
Raquel Alves Sales, Gabriel Carvalhal de Aguiar, Daniel Vitor de Souza, Daniel Araki Ribeiro
{"title":"Oral Cell Cytogenetic Biomarkers for Monitoring Genomic Instability in Fanconi Anemia","authors":"Raquel Alves Sales,&nbsp;Gabriel Carvalhal de Aguiar,&nbsp;Daniel Vitor de Souza,&nbsp;Daniel Araki Ribeiro","doi":"10.1111/jop.70184","DOIUrl":"10.1111/jop.70184","url":null,"abstract":"","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":"55 10","pages":"1084-1085"},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TOP2A Drives Oral Squamous Cell Carcinoma Initiation and Progression Through Activation of the TGF-β2/Smad Signaling Pathway TOP2A通过激活TGF-β2/Smad信号通路驱动口腔鳞状细胞癌的发生和进展。
IF 2.3 3区 医学
Journal of Oral Pathology & Medicine Pub Date : 2026-11-02 Epub Date: 2026-08-31 DOI: 10.1111/jop.70178
Xueying Zhang, Shaohong Zhang, Chong Chen, Shuhan Zhou, Huiming Yu, Wei Zhang
{"title":"TOP2A Drives Oral Squamous Cell Carcinoma Initiation and Progression Through Activation of the TGF-β2/Smad Signaling Pathway","authors":"Xueying Zhang,&nbsp;Shaohong Zhang,&nbsp;Chong Chen,&nbsp;Shuhan Zhou,&nbsp;Huiming Yu,&nbsp;Wei Zhang","doi":"10.1111/jop.70178","DOIUrl":"10.1111/jop.70178","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>TOP2A has been implicated in the progression of multiple malignancies; however, its clinical significance and biological role in OSCC remain poorly understood. This study aimed to comprehensively investigate the expression, prognostic value, biological functions, and molecular mechanisms of TOP2A in OSCC through an integrative, multilevel approach that combined multi-cohort bioinformatics analyses, clinical immunohistochemical validation, and both in vitro and in vivo functional experiments.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Multi-cohort bioinformatics analyses were first performed to evaluate TOP2A expression, prognostic relevance, and potential downstream signaling pathways. These findings were further validated using clinical OSCC specimens by IHC and western blot analysis. The biological functions of TOP2A were assessed through a panel of in vitro functional assays and in vivo xenograft models. Mechanistically, the involvement of the TGF-β2/Smad pathway was examined by integrating transcriptomic profiling with pathway validation and functional rescue experiments using TGF-β2 overexpression.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>TOP2A is aberrantly overexpressed in OSCC, and it was associated with shortened overall survival in affected individuals. TOP2A silencing impaired cell proliferation, invasion, migration, and promoted apoptosis, whereas in vivo it inhibited tumor growth. In addition, TOP2A can activate the TGF-β2/Smad pathway and promote the biological behavior of OSCC cells by this pathway.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>These findings suggest that TOP2A is upregulated in OSCC and may promote tumor progression via the TGF-β2/Smad signaling pathway. Our results support TOP2A as a potential prognostic biomarker and therapeutic target in OSCC.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":"55 10","pages":"1099-1112"},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148865113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书